These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33257031)

  • 1. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.
    Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J
    Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
    Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
    JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies.
    Xu J; Resurreccion WK; Shi Z; Wei J; Wang CH; Zheng SL; Hulick PJ; Ross AE; Pavlovich CP; Helfand BT; Isaacs WB
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):422-430. PubMed ID: 35347252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.
    Chen H; Liu X; Brendler CB; Ankerst DP; Leach RJ; Goodman PJ; Lucia MS; Tangen CM; Wang L; Hsu FC; Sun J; Kader AK; Isaacs WB; Helfand BT; Zheng SL; Thompson IM; Platz EA; Xu J
    Prostate; 2016 Sep; 76(12):1120-9. PubMed ID: 27197965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
    Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J
    Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
    Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
    Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.
    Seibert TM; Garraway IP; Plym A; Mahal BA; Giri V; Jacobs MF; Cheng HH; Loeb S; Helfand BT; Eeles RA; Morgan TM
    Eur Urol; 2023 Mar; 83(3):241-248. PubMed ID: 36609003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases.
    Na R; Ye D; Qi J; Liu F; Lin X; Helfand BT; Brendler CB; Conran C; Gong J; Wu Y; Gao X; Chen Y; Zheng SL; Mo Z; Ding Q; Sun Y; Xu J
    Asian J Androl; 2016; 18(4):525-9. PubMed ID: 27140652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression.
    Xu J; Shi Z; Wei J; Na R; Resurreccion WK; Wang CH; Sample C; Han M; Zheng SL; Cooney KA; Helfand BT; Isaacs WB
    Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):749-754. PubMed ID: 35149774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.
    Xu J; Isaacs WB; Mamawala M; Shi Z; Landis P; Petkewicz J; Wei J; Wang CH; Resurreccion WK; Na R; Bhanji Y; Novakovic K; Walsh PC; Zheng SL; Helfand BT; Pavlovich CP
    Prostate; 2021 Jul; 81(10):703-709. PubMed ID: 33956350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validity and utility of genetic risk scores in prostate cancer.
    Helfand BT; Kearns J; Conran C; Xu J
    Asian J Androl; 2016; 18(4):509-14. PubMed ID: 27297129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population.
    Orsted DD; Nordestgaard BG; Jensen GB; Schnohr P; Bojesen SE
    Eur Urol; 2012 May; 61(5):865-74. PubMed ID: 22104593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.
    Pernar CH; Ebot EM; Pettersson A; Graff RE; Giunchi F; Ahearn TU; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Stopsack KH; Gazeeva E; Lis RT; Parmigiani G; Rimm EB; Finn SP; Giovannucci EL; Fiorentino M; Mucci LA
    Eur Urol; 2019 Jul; 76(1):33-40. PubMed ID: 30301696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between family history of prostate cancer and positive biopsies in a Brazilian screening program.
    Muller RL; Faria EF; Carvalhal GF; Reis RB; Mauad EC; Carvalho AL; Freedland SJ
    World J Urol; 2013 Oct; 31(5):1273-8. PubMed ID: 22820620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in men with a negative prostate biopsy: an interim analysis of a prospective cohort study.
    Sandahl M; Pedersen BG; Ulhøi BP; Borre M; Sørensen KD
    BJU Int; 2021 Dec; 128(6):702-712. PubMed ID: 33964113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.
    Yu H; Shi Z; Wu Y; Wang CH; Lin X; Perschon C; Isaacs WB; Helfand BT; Lilly Zheng S; Duggan D; Mo Z; Lu D; Xu J
    Prostate; 2019 Jul; 79(10):1099-1105. PubMed ID: 31037745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up.
    Rider JR; Wilson KM; Sinnott JA; Kelly RS; Mucci LA; Giovannucci EL
    Eur Urol; 2016 Dec; 70(6):974-982. PubMed ID: 27033442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.
    Wei J; Yang W; Shi Z; Lu L; Wang Q; Resurreccion WK; Engelmann V; Zheng SL; Hulick PJ; Cooney KA; Isaacs WB; Helfand BT; Lu J; Xu J
    Prostate; 2021 Sep; 81(13):1002-1008. PubMed ID: 34254341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of genetic risk score with family history for estimating prostate cancer risk.
    Helfand BT
    Asian J Androl; 2016; 18(4):515-9. PubMed ID: 27004541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.
    Islami F; Moreira DM; Boffetta P; Freedland SJ
    Eur Urol; 2014 Dec; 66(6):1054-64. PubMed ID: 25242554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.